Dalbavancin for prosthetic joint infections: Empirical treatment
This study provides data outside of the marketing authorization, while respecting the authorized dosage in a population of patients with clearly defined inclusion criteria and a two-year follow-up.
Authors
- Guido Giordano (ORCID: https://orcid.org/0000-0002-5819-443X)
- A Bouige
- É. Bonnet (ORCID: https://orcid.org/0000-0002-4030-7248)
- Mehdi Merouani
- P Marlin
- G Krin
- L Gautié
- C. R. Fourcade (ORCID: https://orcid.org/0000-0002-9692-8414)
- P. Gandia
- S. Baklouti
- R Mairesse
Institutions
- Médipole Garonne (FR)
- Hôpital Joseph-Ducuing (FR)
- Hôpital Paule de Viguier (FR)
Publication Details
- Journal
- Infectious Diseases Now
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1016/j.idnow.2025.105035
- Citations
- 3
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.02